|
||
|
|||
Contents Page 1 |
My Chitosan Experiment And Price ComparisonTo the best of my knowledge, there is no human research that has used a dose of chitosan/vitamin C designed to match the effectiveness of Xenical. I wanted to see if such a dose would cause undesirable side effects, so I decided to try a low dose and a high dose of the chitosan/vitamin C combination. I was also curious to see how the cost would compare with Xenical. Since I could not find a product that was properly formulated, purchasing the ingredients separately seemed to be the only option. The ingredients must be in gelatin capsules, and you want real vitamin C (ascorbic acid), not buffered C or Ester-C. So I surfed around a bit and WebVitamins seemed to have good prices on suitable ingredients: Low Dose Chitosan/Vitamin C High Dose Chitosan/Vitamin C |
||
Warning: the doses of chitosan that I discuss exceed the recommendations of most supplement manufacturers. See our Terms of Service for more information. Note: this chart is based on the 3.4g/g results of the in vivo Kanauchi et al. chitosan study (5), patient information from Hoffmann-La Roche, and a web-based price survey performed in Aug 2001. |
![]() |
||
Natrol Chitosan: 360 capsules (500 mg). Twinlab C-1000: 250 capsules (1000 mg).
Written |
Whenever I take something new, I always start with a VERY low dose to see how I react to it. So I started off with just one capsule of chitosan and worked my way up to the Low Dose Chitosan/Vitamin C combination. This was taken 30 minutes before the meal. At this dose, the only notable thing was slightly *enhanced* elimination due to the increased fiber intake. Perhaps because the fat is enveloped in the chitosan gel, I found that I could eat a high fat meal without experiencing any Xenical type side effects. In fact, no diarrhea or constipation was found in rats fed a diet containing 10% chitosan (a monster dose!) (8). Since the low dose experiment went fine, I decided to work my way up to the High Dose Chitosan/Vitamin C combination. This dose seemed to have an appetite-suppressing effect. Of course, it could be a placebo effect, but I found a study where chitosan had an appetite suppressing effect on chickens: "Feeding of the chitosan diet to chickens significantly reduced body weights and feed intakes compared with animals fed on control or pectin diets on days 5 and 11 of the experiment" (9). High dose chitosan also seems to have an appetite suppressing effect on rats: "However, food intake and body weight gain of rats fed the diet containing 5% of chitosan were definitely lower than not only the other fiber including diet groups but also the control group" (10). On the other hand, a couple of studies found that high doses of chitosan did not influence food intake (8, 22). Of course, consuming such a large amount of fiber affects your bowel movements, but I found the High Dose Chitosan/Vitamin C combination to be remarkably free of side effects. I don't know if people with sensitive stomachs would have a problem with the high dose. However, if the chitosan/vitamin C combination blocks fat as well in humans as in the animal studies, it has a number of advantages:
|
|
Home |
1.) Guerciolini R; Radu-Radulescu L; Boldrin M; Dallas J, and Moore R. "Comparative evaluation of fecal fat excretion induced by orlistat and chitosan." Obes Res, 2001 Jun; Vol: 9; Number: 6; Page: 364-7; PMID: 11399783. 2.) Pittler MH; Abbot NC; Harkness EF, and Ernst E. "Randomized, double-blind trial of chitosan for body weight reduction." Eur J Clin Nutr, 1999 May; Vol: 53; Number: 5; Page: 379-81; PMID: 0010369493. 3.) Wuolijoki E; Hirvela T, and Ylitalo P. "Decrease in serum LDL cholesterol with microcrystalline chitosan." Methods Find Exp Clin Pharmacol, 1999 Jun; Vol: 21; Number: 5; Page: 357-61; PMID: 0010420392. 4-NA.) Kanauchi O; Deuchi K; Imasato Y; and Kobayashi E. "Increasing effect of a chitosan and ascorbic acid mixture on fecal dietary fat excretion." Biosci Biotechnol Biochem, 1994; Vol: 58; Page: 1617-20. 5.) Kanauchi O; Deuchi K; Imasato Y; Shizukuishi M, and Kobayashi E. "Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate." Biosci Biotechnol Biochem, 1995 May; Vol: 59; Number: 5; Page: 786-90; PMID: 0007787293. 6.) Deuchi K; Kanauchi O; Imasato Y, and Kobayashi E. "Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high-fat diet." Biosci Biotechnol Biochem, 1995 May; Vol: 59; Number: 5; Page: 781-5; PMID: 0007787292. 7-BK.) Fox, Arnold and Adderly, Brenda. "The Fat Blocker Diet." New York: St. Martin's Press; 1997; ISBN: 0-312-17102-1. 8.) Sugano M; Fujikawa T; Hiratsuji Y; Nakashima K; Fukuda N, and Hasegawa Y. "A novel use of chitosan as a hypocholesterolemic agent in rats." Am J Clin Nutr, 1980 Apr; Vol: 33; Number: 4; Page: 787-93; PMID: 0007361697. 9.) Razdan A; Pettersson D, and Pettersson J. "Broiler chicken body weights, feed intakes, plasma lipid and small- intestinal bile acid concentrations in response to feeding of chitosan and pectin." Br J Nutr, 1997 Aug; Vol: 78; Number: 2; Page: 283-91; PMID: 0009301417. 10.) Kondo H and Osada A. "Influence of dietary fiber on the bioavailability of zinc in rats." Biomed Environ Sci, 1996 Sep; Vol: 9; Number: 2-3; Page: 204-8; PMID: 0008886332. 11.) Deuchi K; Kanauchi O; Shizukuishi M, and Kobayashi E. "Continuous and massive intake of chitosan affects mineral and fat- soluble vitamin status in rats fed on a high-fat diet." Biosci Biotechnol Biochem, 1995 Jul; Vol: 59; Number: 7; Page: 1211-6; PMID: 0007670180. 12.) Wada M; Nishimura Y; Watanabe Y; Takita T, and Innami S. "Accelerating effect of chitosan intake on urinary calcium excretion by rats." Biosci Biotechnol Biochem, 1997 Jul; Vol: 61; Number: 7; Page: 1206-8; PMID: 0009255987. 13.) Razdan A and Pettersson D. "Hypolipidaemic, gastrointestinal and related responses of broiler chickens to chitosans of different viscosity." Br J Nutr, 1996 Sep; Vol: 76; Number: 3; Page: 387-97; PMID: 0008881711. 14.) Zacour AC; Silva ME; Cecon PR; Bambirra EA, and Vieira EC. "Effect of dietary chitin on cholesterol absorption and metabolism in rats." J Nutr Sci Vitaminol (Tokyo), 1992 Dec; Vol: 38; Number: 6; Page: 609-13; PMID: 0001304604. 15.) Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J, and Hauptman J. "Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study." Diabetes Care, 1998 Aug; Vol: 21; Number: 8; Page: 1288-94; PMID: 0009702435. 16.) Melia AT; Koss-Twardy SG, and Zhi J. "The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers." J Clin Pharmacol, 1996 Jul; Vol: 36; Number: 7; Page: 647-53; PMID: 0008844448. 17.) Ormrod DJ; Holmes CC, and Miller TE. "Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis." Atherosclerosis, 1998 Jun; Vol: 138; Number: 2; Page: 329-34; PMID: 0009690916. 18.) Gallaher CM; Munion J; Hesslink R Jr; Wise J, and Gallaher DD. "Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats." J Nutr, 2000 Nov; Vol: 130; Number: 11; Page: 2753-9; PMID: 11053517. 19.) LeHoux JG and Grondin F. "Some effects of chitosan on liver function in the rat." Endocrinology, 1993 Mar; Vol: 132; Number: 3; Page: 1078-84; PMID: 0007679967. 20.) Kondo Y; Nakatani A; Hayashi K, and Ito M. "Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice." Biol Pharm Bull, 2000 Dec; Vol: 23; Number: 12; Page: 1458-64; PMID: 11145178. 21.) Miura T; Usami M; Tsuura Y; Ishida H, and Seino Y. "Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice." Biol Pharm Bull, 1995 Nov; Vol: 18; Number: 11; Page: 1623-5; PMID: 0008593495. 22.) Jennings CD; Boleyn K; Bridges SR; Wood PJ, and Anderson JW. "A comparison of the lipid-lowering and intestinal morphological effects of cholestyramine, chitosan, and oat gum in rats." Proc Soc Exp Biol Med, 1988 Oct; Vol: 189; Number: 1; Page: 13-20; PMID: 0003186761. |
||